We only have this paper's title and publication details.
Read it at the sourceA novel series of 3-aryl and 3-heteroarylcoumarins displaying tyrosinase inhibitory activity.
No takes yet. Share an insight, caveat, or question.
Matos et al. (2015) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: